Navigating an executive leadership change? Use our eBook to facilitate a smooth transition. Download Now

Westicke Partners

Close

Posts by Darcie Robinson

Is the Biotech IPO Market Coming Back? How to Prepare

Posted on August 23rd, 2022. Posted by and

Lab worker looking into microscope in biotech lab

The second quarter of 2022 was the weakest quarter for healthcare and biotech IPOs in more than five years. Some media headlines have predicted that it marked the bottom of the biotech market. 

The XBI biotech index fund, which serves as an index for many companies that are eyeing a public debut, peaked in January 2021 followed by a fairly steady 16-month decline. But now, the XBI is on the rise. While it’s too soon to know if the XBI rise that kicked off in July 2022 will continue to mirror the rise that drove its 2021 peak, the climb appears to be signaling a comeback of healthcare and biotech IPOs.  

If you’re watching the fund, you might now be considering reviving your plans to take your company public.

Continue Reading

Have News to Release?

Find out whether you should file a Form 8-K, issue a press release, or do both by using our easy-to-reference chart, “Form 8K vs. Press Release: What’s the Difference?

Our Locations